Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/2162402X.2017.1314424 http://scihub22266oqcxt.onion/10.1080/2162402X.2017.1314424 C5467995!5467995!28638743     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncoimmunology 2017 ; 6 (5): ä Nephropedia Template TP {{tp|p=28638743|t=2017. Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications |pdf=|usr=}}{{28638743}} gab.com Text Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications JO: Oncoimmunology http://www.kidney.de/pget.php?&tw=1&pmid=28638743 #FOAvip If there is a great new hope in the treatment of cancer, the immune system is it. Innate and adaptive immunity either promote or attenuate tumorigenesis and so can have opposing effects on the therapeutic outcome. Originally described as potent antivirals, Type-I interferons (IFNs) were quickly recognized as central coordinators of tumor-immune system interactions. Type-I-IFNs are produced by, and act on, both tumor and immune cells being either host-protecting or tumor-promoting. Here, we discuss Type-I-IFNs in infectious and cancer diseases highlighting their dichotomous role and raising the importance to deeply understand the underlying mechanisms so to reshape the way we can exploit Type-I-IFNs therapeutically. Twit Text FOAVip Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications ????Oncoimmunology http://www.kidney.de/pget.php?&tw=1&pmid=28638743 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28638743 #FOAvip English Wikipedia <ref>{{Cite pmid|28638743}}</ref> Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications #MMPMID28638743 Musella M; Manic G; De Maria R; Vitale I; Sistigu A Oncoimmunology 2017[]; 6 (5): ä PMID28638743show ga If there is a great new hope in the treatment of cancer, the immune system is it. Innate and adaptive immunity either promote or attenuate tumorigenesis and so can have opposing effects on the therapeutic outcome. Originally described as potent antivirals, Type-I interferons (IFNs) were quickly recognized as central coordinators of tumor-immune system interactions. Type-I-IFNs are produced by, and act on, both tumor and immune cells being either host-protecting or tumor-promoting. Here, we discuss Type-I-IFNs in infectious and cancer diseases highlighting their dichotomous role and raising the importance to deeply understand the underlying mechanisms so to reshape the way we can exploit Type-I-IFNs therapeutically. äType-I-interferons in infection and cancer: Unanticipated dynamics wit(epmc).pdf DeepDyve Pubget Overpricing